http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112016021835-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2b25cf8265f5391a0e721a91c17826e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
filingDate 2015-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c865316deffa222ddd8ba4919943ebaf
publicationDate 2018-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112016021835-A8
titleOfInvention cyclic analog of apelin of general formula x1-x2-x3-x4-x5-x6-x7-x8-x9-x10-x11-x12-x13-x14, pharmaceutical composition, and method for providing an analogue of apelin
abstract The invention relates to the field of pharmacology. in particular, it relates to novel apelin analogs, and their therapeutic uses. A cyclic analog of apine of formula x1-x2-x3-x4-x5-x6-x7-x8-x9-x10-x11-x12-x13-x14, comprising a lanthionine bridge having the ala-s- ala or a methylthionine bridge having the abu-s-ala or ala-s-abu structure and wherein said (methyl) lanthionine bridge is size i, i + 3; i, i + 4, i, i + 5 or i, i + 6.
priorityDate 2014-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TUI9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID798375
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4TTN8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9ULZ1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423545145
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9R0R3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56841713
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58812
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9R0R4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30878
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8862

Total number of triples: 38.